200 169110 advanced:3.55891312765391 case:3.24045939653538 1987:0.489454245962768 year:1.51122028428865 clipping:3.24045939653538 reason:3.55891312765391 cancer:4.63203032133495 case:0.975446070875874 author:7.69319040021138 part:4.02891675689965 cohort:2.32203570971108 investigators:3.37422190150464 control:2.75956739411595 design:2.29943659920322 draw:1.80971327284465 population:14.8356224663214 grow:0.802072762382268 study:1.94947521521981 eric:4.53974238066564 study:0.90215622093925 figure:1.80971327284465 men:2.38025813131226 follow:3.06970245747747 men:2.38025813131226 back:3.84659520010569 nested:4.9452074887738 gonna:3.55891312765391 entire:3.15344801954575 biological:0.60791674794131 health:4.04368568455605 study:3.80672045060016 free:1.44869992730732 questionnaire:2.27105883934727 year:0.675510039073838 started:1.66806275578162 50000:3.84659520010569 giovannucci:9.8904149775476 levels:3.22201943359773 hypothesis:1.66806275578162 lorelei:4.53974238066564 specimens:2.74798291143758 ed:0.793215308548206 1986:6.80844275158845 mucci:4.25206030821386 source:8.50412061642772 nested:8.79091340469462 nail:1.0844777777332 health:0.514390689930487 factors:0.867670044868081 professionals:10.3233902759926 prostate:7.69319040021138 study:2.38025813131226 invited:2.74798291143758 larry:1.17244655067916 interesting:0.834333624600489 hypothesis:1.38985942728439 levels:1.49521994294221 remember:0.417998844255421 researchers:3.89895043043962 rimm:4.53974238066564 risk:0.614474148487469 selenium:11.5397856003171 toenails:5.09462443195086 previous:3.69244452027843 started:1.49601108222398 published:2.99929733971849 study:5.32836751264083 biomarkers:1.71846235244443 talk:0.84683782344952 thought:3.84956520525888 thought:24.1735005413979 clark:1.54401010711165 undertook:9.07948476133128 1996:0.956223442209526 men:1.4551892245079
169110 223500 basically:7.11782625530782 1994:1.28164584264415 prostate:4.63203032133495 cancer:1.30059476116783 sampling:2.75956739411595 1988:0.87618073453599 ended:0.802072762382268 follow:1.02323415249249 set:1.34789522818535 risk:1.83169217956343 identified:0.810040932031445 remember:0.526366880977203 case:2.72337710063538 cancer:5.86060893646308 means:0.153557735843091 cases:1.57791165878733 risk:1.78820706762369 sampling:3.44113009199753 advanced:11.5397856003171 select:0.417998844255421 cancer:2.45789659394988 undertook:1.33708273951549 set:2.89739985461464 cases:1.12699344128658 study:0.888061252106805 risk:0.0700101655726489 prostate:4.53974238066564
223500 262340 develop:3.55891312765391 cancer:3.0880202142233 follow:0.325148690291958 clark:3.84659520010569 compare:0.634408363388287 men:0.87618073453599 epidemiological:2.41947884446554 find:0.778542264972074 follow:3.06970245747747 found:1.76715365842585 health:1.34789522818535 larry:4.9452074887738 selenium:1.07400647786591 toenails:0.396607654274103 melanoma:4.53974238066564 men:4.08506565095307 follow:0.153557735843091 population:0.514390689930487 professionals:3.44113009199753 advanced:3.84659520010569 randomized:1.17244655067916 researchers:1.94947521521981 results:0.634408363388287 measured:3.84659520010569 skin:3.69244452027843 source:2.54731221597543 specimen:3.69244452027843 study:0.888061252106805 toenail:12.0867502706989 trial:1.54401010711165 toenails:0.970126149671934
262340 267320 calculate:0.550758334101362 controls:0.919855798038651 measure:0.396607654274103 odds:0.984394319176222 ratios:0.654748047625409
267320 306230 developing:3.55891312765391 prostate:1.54401010711165 trial:1.14971829960161 cancer:0.634408363388287 thinking:3.44113009199753 paper:2.11199414471758 risk:0.87618073453599 risk:0.748005541111992 found:1.76715365842585 highest:3.15344801954575 levels:2.14801295573182 estimate:0.984394319176222 60:1.47947158597407 men:3.44113009199753 men:2.72337710063538 read:1.7263316639056 advanced:3.84659520010569 talk:0.520360856916991 results:1.17244655067916 chance:1.52748080516043 relative:4.68503560665884 line:0.634408363388287 risk:1.84342244546241 selenium:3.84659520010569 critiquing:0.296020417368935 detail:0.42341891172476 questions:1.83169217956343 toenails:4.02891675689965 randomized:1.54401010711165
306230 386180 question:2.14184710786727 case:7.11782625530782 authors:3.24045939653538 address:0.550758334101362 prostate:4.63203032133495 case:0.975446070875874 cohort:2.32203570971108 bit:2.4603008389858 conducted:2.54731221597543 control:3.6794231921546 risk:1.68711095075232 sampling:1.14971829960161 participant:5.00418826734486 question:1.9747930232041 diagnosed:5.73153189418792 researchers:1.83169217956343 cohort:2.69391569016731 nested:2.93030446823154 potential:0.153557735843091 discuss:7.69913041051776 number:0.582108863985438 source:0.514390689930487 participant:2.95894317194814 complex:2.80514132527753 advanced:11.5397856003171 question:3.12216514150195 design:1.94947521521981 principles:2.45789659394988 set:2.00562410927323 risk:1.12699344128658 control:2.54731221597543 study:0.59204083473787
386180 476700 20:1.70652903660942 finally:5.9243790696123 potential:2.64262239577975 case:0.650297380583916 simply:2.59383223161032 exposure:2.59383223161032 exposure:1.92478260262944 exposure:2.08300660784433 question:1.49521994294221 measurement:4.25206030821386 diagnosed:1.66806275578162 study:0.725699783597694 core:1.43366204994278 divided:0.462204936759917 relative:0.748005541111992 selenium:7.76729548488036 measurement:1.21951406153715 interpretation:0.778542264972074 risk:3.55891312765391 gonna:2.34251780332942 equal:0.249282939517245 reflect:0.60791674794131 reflect:5.84842564565943 recently:1.52748080516043 selenium:1.07400647786591 findings:1.66806275578162 relates:1.98303827137052 exposure:9.8904149775476 study:2.95894317194814 1990:1.56108257075097 groups:4.53974238066564 ago:3.07340531187221 measurement:2.99043988588442 bias:2.34251780332942 question:2.5632916852883 influence:0.614474148487469 measurement:11.5397856003171 oftentimes:2.59383223161032 exposure:0.888061252106805 study:0.209009040379305 quintiles:2.38025813131226 happened:0.485063074835967 case:4.25206030821386
476700 518559 secondary:1.14971829960161 studies:3.55891312765391 selenium:1.40424816473649 risk:1.54401010711165 clark:3.84659520010569 compare:1.26881672677657 contrast:3.3357695763397 randomized:2.41947884446554 final:1.21951406153715 1996:1.76715365842585 larry:4.9452074887738 selenium:1.47947158597407 analysis:2.72337710063538 men:2.5028604534046 lower:3.84659520010569 published:2.38025813131226 question:1.04072171383398 randomized:3.51733965203748 relates:1.28164584264415 60:0.614474148487469 found:4.02891675689965 randomized:7.69319040021138 study:1.48010208684467 subsequent:3.07340531187221 biomarkers:4.02891675689965 undertaken:9.07948476133128
518558 560670 advanced:3.55891312765391 agent:2.93030446823154 ago:1.70652903660942 association:1.11656609228471 based:1.00362568110411 cancer:7.72005053555825 chemo:4.9452074887738 conducted:2.54731221597543 data:0.231182897873627 epidemiological:2.41947884446554 found:1.76715365842585 states:2.64262239577975 institute:3.3357695763397 inverse:2.99929733971849 levels:1.07400647786591 35000:1.36168855031769 national:2.4603008389858 potential:1.47947158597407 preventive:5.18766446322064 primary:2.38025813131226 prostate:15.3863808004228 recruited:3.07340531187221 risk:1.22894829697494 select:2.89739985461464 selenium:11.5397856003171 specifically:1.29454924748006 united:1.41884696415764 study:0.296020417368935 thinking:1.83169217956343 trail:4.9452074887738 trial:1.54401010711165 undertaken:4.53974238066564 undertook:4.53974238066564 men:1.70652903660942 years:0.485063074835967
560670 654100 question:2.02743675668952 forward:0.538488241509547 association:1.11656609228471 average:2.1689555554664 confounding:1.9747930232041 called:0.281768394661733 cancer:4.63203032133495 clark:3.84659520010569 providing:2.86576594709396 question:0.634408363388287 study:1.9747930232041 study:2.08300660784433 explanations:1.36168855031769 contrast:3.3357695763397 randomized:1.8397115960773 study:6.88226018399506 design:1.14971829960161 diagnosis:2.64262239577975 advantages:2.99929733971849 protective:0.96552583487184 epidemiological:7.25843653339662 found:1.87715455364018 plausible:2.38025813131226 interpretation:1.29454924748006 factorial:3.44113009199753 study:1.21951406153715 follow:1.02323415249249 question:2.30615015915854 found:3.5343073168517 cancer:2.64262239577975 bias:1.52748080516043 larry:4.9452074887738 questions:3.24045939653538 post:2.34251780332942 exposure:0.654748047625409 letting:1.0844777777332 placebo:2.5028604534046 concerned:3.44113009199753 answers:2.86576594709396 supplementation:2.59383223161032 prostate:7.69319040021138 evidence:3.07340531187221 logging:2.05483573087764 published:2.38025813131226 guess:2.08144342766796 randomized:4.68978620271664 received:1.87715455364018 relative:2.34251780332942 results:0.634408363388287 risk:1.22894829697494 selenium:15.3863808004228 study:2.36816333895148 selenium:3.69244452027843 comments:1.92478260262944 time:0.0700101655726489 control:1.54401010711165 vitamin:5.99859467943698 years:0.485063074835967
